Is this you? Create Your Porfile
Avatar

Robert J. Rafka

Pfizer

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Robert J. Rafka is active.

Explore More

Publication

Featured researches published by Robert J. Rafka.

Bioorganic & Medicinal Chemistry Letters | 2006

5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part 1: Structure-activity relationship studies of 5-alkylamino pyrazoles and discovery of a potent, selective, and orally active analog

Subas M. Sakya; Kristin Lundy DeMello; Martha L. Minich; Bryson Rast; Andrei Shavnya; Robert J. Rafka; David A. Koss; Hengmiao Cheng; Jin Li; Burton H. Jaynes; Carl Bernard Ziegler; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Annette M. Silvia; David M. George; Lisa A. Lund; Suzanne H. St. Denis; Anne Hickman; Michelle L. Haven; Michael P. Lynch

Organic Letters | 2011

Mild decarboxylative activation of malonic acid derivatives by 1,1'-carbonyldiimidazole.

Danny Lafrance; Paul Bowles; Kyle R. Leeman; Robert J. Rafka

Journal of Agricultural and Food Chemistry | 2004

An Analytical Method for the Analysis of Tulathromycin, an Equilibrating Triamilide, in Bovine and Porcine Plasma and Lung

Diana Galer; Scott Hessong; Brian Beato; James Risk; Philip B. Inskeep; Chandralal A. Weerasinghe; Richard P. Schneider; Connie Langer; Jennifer Laperle; Donald Renouf; Andrew J. Bessire; Eden Espanol; Robert J. Rafka; Colman Brendan Ragan; Wayne Boettner; Trisha Murphy; David Keller; Hafid Benchaoui; Marcus A. Nowakowski

Bioorganic & Medicinal Chemistry Letters | 2006

Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.

Hengmiao Cheng; Kristin Lundy DeMello; Jin Li; Subas M. Sakya; Kazuo Ando; Kiyoshi Kawamura; Tomoki Kato; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Rod Stevens; Lisa A. Lund; Donald W. Mann; Carolyn Rose Kilroy; Michelle L. Haven; Erik L. Nimz; Jason K. Dutra; Chao Li; Martha L. Minich; Nicole L. Kolosko; Carol F. Petras; Annette M. Silvia; Scott B. Seibel

Bioorganic & Medicinal Chemistry Letters | 2004

Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridine.

Jin Li; Kristin Lundy DeMello; Henry Cheng; Subas M. Sakya; Brian Scott Bronk; Robert J. Rafka; Burton H. Jaynes; Carl Bernard Ziegler; Carolyn Rose Kilroy; Donald W. Mann; Eric L. Nimz; Michael P. Lynch; Michelle L. Haven; Nicole L. Kolosko; Martha L. Minich; Chao Li; Jason K. Dutra; Bryson Rast; Rhonda Marie Crosson; Barry James Morton; Glen W. Kirk; Kathleen M. Callaghan; David A. Koss; Andrei Shavnya; Lisa A. Lund; Scott B. Seibel; Carol F. Petras; Annette M. Silvia

Archive | 1999

13-membered azalides and their use as antibiotic agents

Robert J. Rafka; Barry James Morton; Colman Brendan Ragan; Peter Bertinato; John P. Dirlam; Alan Elwood Blize; Carl Bernard Ziegler

Bioorganic & Medicinal Chemistry Letters | 2006

5-Heteroatom-substituted pyrazoles as canine COX-2 inhibitors: Part 2. Structure–activity relationship studies of 5-alkylethers and 5-thioethers

Subas M. Sakya; Hengmiao Cheng; Kristin Lundy DeMello; Andrei Shavnya; Martha L. Minich; Bryson Rast; Jason K. Dutra; Chao Li; Robert J. Rafka; David A. Koss; Jin Li; Burton H. Jaynes; Carl Bernard Ziegler; Donald W. Mann; Carol F. Petras; Scott B. Seibel; Annette M. Silvia; David M. George; Anne Hickman; Michelle L. Haven; Michael P. Lynch

Bioorganic & Medicinal Chemistry | 2005

In vitro and in vivo profile of 2-(3-di-fluoromethyl-5-phenylpyrazol-1-yl)-5-methanesulfonylpyridine, a potent, selective, and orally active canine COX-2 inhibitor

Jin Li; Michael P. Lynch; Kristin Lundy DeMello; Subas M. Sakya; Hengmiao Cheng; Robert J. Rafka; Brian Scott Bronk; Burton H. Jaynes; Carolyn Rose Kilroy; Donald W. Mann; Michelle L. Haven; Nicole L. Kolosko; Carol F. Petras; Scott B. Seibel; Lisa A. Lund

Archive | 2000

NOVEL CRYSTALLINE FORMS OF A MACROLIDE ANTIBIOTIC

Robert J. Rafka; Douglas John Meldrum Allen; Colman Brendan Ragan; Barry James Morton

Archive | 2004

Diphosphate salt of a "4" - substituted-9-deoxo-9 A - AZA - homoerythromycin derivatives and its pharmaceutical composition

Robert J. Rafka; Colman Brendan Ragan; Douglas John Meldrum Allen

Explore More

Collaboration

Dive into the Robert J. Rafka's collaboration.

Top Co-Authors
Avatar

Colman Brendan Ragan

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Burton H. Jaynes

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Carl Bernard Ziegler

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Carol F. Petras

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Donald W. Mann

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Jason K. Dutra

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Jin Li

Children's Hospital of Philadelphia

View shared research outputs
Top Co-Authors
Avatar

Kristin Lundy DeMello

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Michelle L. Haven

Pfizer

View shared research outputs
Top Co-Authors
Avatar

Scott B. Seibel

Pfizer

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge